PRICE INQUIRY no. SEMA/5/2023/API - being conducted as a market assessment study 

PRICE INQUIRY no. SEMA/5/2023/API - being conducted as a market assessment study 

In connection with the implementation of the project titled “Design and development of an innovative solution - a generic drug belonging to the class of GLP-1 recept”, funded from the state budget by the Medical Research Agency, WZA Polfa Warszawa S.A., you are kindly requested to submit a bid for the purchase and delivery of the active substance Semaglutide. Details of the price inquiry can be found in the documents attached below. 

go back